BE Biopharma

Biotech

be.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
0 granted · 40 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2107NEUROTHERANOSTICS, INC.——
2108Twenty-Two Desserts, Inc.—$1.4M
2109AVIVA BIOSCIENCES CORP—$500K
2110BE Biopharma——
2111FRUGI BIOTECHNOLOGY INC.——
2112APC BIO INNOVATIONS INC——
2113ABILITY DYNAMICS, L.L.C.—$1.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 40
  • Engineered Cell Preparations For Treatment Of Niemann Pick B Diseaseapplication
  • Compositions And Methods For Multiplex Engineering Of Immune Cellsapplication
  • Engineered Cell Preparations For Treatment Of Hemophiliaapplication
  • Methods Of Cell Preservationapplication
  • Allogeneic Cell Compositions And Methods Thereofapplication
  • Engineered Cell Preparations For Treatment Of Hypophosphatasiaapplication
  • Engineered Cell Preparationsapplication
  • Engineered Cell Preparations For Treatment Of Hypophosphatasiaapplication
  • Engineered Cell Preparations For Treatment Of Hypophosphatasiaapplication
  • Compositions And Methods For Production Of Enhanced Engraftable Populations Of Engineered Immune Cellsapplication
  • Compositions And Methods For Production Of Engineered Immune Cellsapplication
  • Allogeneic Cell Compositions And Methods Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.